UnitedHealth Group Incorporated Peer Comparison
| Metric | Value | Ranking | |||||||
|---|---|---|---|---|---|---|---|---|---|
| Market Cap | $478.3 Billion | 1/7 | UNH $478.3B |
CI $80.4B |
CVS $66.7B |
HUM $34.3B |
CNC $32.1B |
MOH $17.3B |
ALHC $2.8B |
| Gross Margin | 21% | 3/7 | HUM 89% |
CI 85% |
UNH 21% |
ALHC 11% |
CNC 10% |
CVS -55% |
MOH -68% |
| Profit Margin | 5% | 1/7 | UNH 5% |
MOH 3% |
CNC 2% |
HUM 2% |
CVS 0% |
CI 0% |
ALHC -4% |
| EBITDA margin | 5% | 1/7 | UNH 5% |
MOH 5% |
CI 4% |
CNC 3% |
HUM 3% |
CVS 1% |
ALHC -2% |
| Quarterly Revenue | $100.8 Billion | 1/7 | UNH $100.8B |
CVS $95.4B |
CI $63.7B |
CNC $42.0B |
HUM $29.4B |
MOH $10.4B |
ALHC $692.4M |
| Quarterly Earnings | $5.5 Billion | 1/7 | UNH $5.5B |
CNC $713.0M |
HUM $480.0M |
MOH $326.0M |
CVS $87.0M |
CI $86.0M |
ALHC -$26.4M |
| Quarterly Free Cash Flow | $0 Billion | 7/7 | HUM $1.7B |
MOH $927.0M |
ALHC $16.9M |
CI -$353.0M |
CNC -$1.1B |
CVS -$1.4B |
UNH -$0 |
| Trailing 4 Quarters Revenue | $401.3 Billion | 1/7 | UNH $401.3B |
CVS $369.0B |
CI $232.5B |
CNC $161.7B |
HUM $115.0B |
MOH $39.2B |
ALHC $2.5B |
| Trailing 4 Quarters Earnings | $22.3 Billion | 1/7 | UNH $100.8B |
CVS $95.4B |
CI $63.7B |
CNC $42.0B |
HUM $29.4B |
MOH $10.4B |
ALHC $692.4M |
| Quarterly Earnings Growth | 2% | 5/7 | CI 110% |
CNC 52% |
MOH 33% |
ALHC 25% |
UNH 2% |
HUM -42% |
CVS -96% |
| Annual Earnings Growth | -3% | 2/7 | MOH -2% |
UNH -3% |
CNC -16% |
ALHC -20% |
CVS -37% |
CI -38% |
HUM -63% |
| Quarterly Revenue Growth | 7% | 6/7 | ALHC 52% |
CI 30% |
MOH 21% |
HUM 11% |
CNC 10% |
UNH 7% |
CVS 6% |
| Annual Revenue Growth | 8% | 4/7 | ALHC 34% |
CI 19% |
MOH 17% |
UNH 8% |
HUM 8% |
CNC 7% |
CVS 3% |
| Cash On Hand | $29.1 Billion | 1/7 | UNH $29.1B |
CNC $14.6B |
CVS $6.9B |
CI $5.9B |
HUM $5.1B |
MOH $4.7B |
ALHC $340.3M |
| Short Term Debt | $4.5 Billion | 1/7 | UNH $4.5B |
CI $2.6B |
HUM $1.1B |
CVS $800.0M |
CNC $111.0M |
ALHC $1.6M |
MOH -$1.2B |
| Long Term Debt | $0 | 7/7 | CVS $75.1B |
CI $30.2B |
CNC $17.5B |
HUM $11.9B |
MOH $2.5B |
ALHC $210.4M |
UNH $0 |
| PE | 21.49 | 3/7 | CI 29.47 |
HUM 25.24 |
UNH 21.49 |
MOH 15.13 |
CVS 13.29 |
CNC 10.46 |
ALHC -1.00 |
| PS | 1.19 | 1/7 | UNH 1.19 |
ALHC 1.13 |
MOH 0.44 |
CI 0.35 |
HUM 0.30 |
CNC 0.20 |
CVS 0.18 |
| PB | 1.60 | 5/7 | ALHC 24.22 |
MOH 3.63 |
HUM 1.95 |
CI 1.90 |
UNH 1.60 |
CNC 1.17 |
CVS 0.89 |
| PC | 16.43 | 1/7 | UNH 16.43 |
CI 13.65 |
CVS 9.70 |
ALHC 8.23 |
HUM 6.71 |
MOH 3.66 |
CNC 2.20 |
| Liabilities to Equity | 0.00 | 7/7 | ALHC 5.03 |
CI 2.74 |
CVS 2.37 |
MOH 2.30 |
CNC 2.01 |
HUM 1.84 |
UNH 0.00 |
| ROA | 0.07 | 1/7 | UNH 7% | MOH 7% | CNC 4% | HUM 3% | CVS 2% | CI 2% | ALHC -21% |
| ROE | -1.00 | 6/7 | MOH 24% |
CNC 11% |
HUM 8% |
CVS 7% |
CI 6% |
UNH -100% |
ALHC -126% |
| Current Ratio | -1.00 | 7/7 | HUM 1.54 |
CNC 1.50 |
MOH 1.43 |
CVS 1.42 |
CI 1.37 |
ALHC 1.20 |
UNH -1.00 |
| Quick Ratio | -1.00 | 7/7 | CI 29.47 |
HUM 25.24 |
UNH 21.49 |
MOH 15.13 |
CVS 13.29 |
CNC 10.46 |
ALHC -1.00 |
| Long Term Debt to Equity | -1.00 | 7/7 | ALHC} 1.84 |
CVS} 1.00 |
CI} 0.72 |
HUM} 0.68 |
CNC} 0.64 |
MOH} 0.53 |
UNH} -1.00 |
| Debt to Equity | -1.00 | 7/7 | ALHC 1.85 |
CVS 1.01 |
CI 0.78 |
HUM 0.74 |
CNC 0.64 |
MOH 0.53 |
UNH -1.00 |
| Burn Rate | -6.61 | 6/7 | CNC 1004.62 |
HUM 18.31 |
ALHC 9.66 |
CI 3.33 |
CVS 2.21 |
UNH -6.61 |
MOH -8.95 |
| Cash to Cap | 0.06 | 7/7 | CNC 0.45 |
MOH 0.27 |
HUM 0.15 |
ALHC 0.12 |
CVS 0.10 |
CI 0.07 |
UNH 0.06 |
| CCR | 7/7 | HUM 3.60 |
MOH 2.84 |
ALHC -0.64 |
CNC -1.59 |
CI -4.10 |
CVS -16.26 |
UNH |
|
| EV to EBITDA | 99.20 | 2/7 | CVS} 163.09 |
UNH} 99.20 |
CI} 41.66 |
HUM} 41.63 |
MOH} 29.40 |
CNC} 24.90 |
ALHC} -226.20 |
| EV to Revenue | 1.13 | 1/7 | UNH 1.13 |
ALHC 1.08 |
CI 0.46 |
MOH 0.39 |
CVS 0.37 |
HUM 0.37 |
CNC 0.22 |